142 related articles for article (PubMed ID: 20299822)
1. Investigations into the binding affinities of different human 5-HT4 receptor splice variants.
Irving HR; Tochon-Danguy N; Chinkwo KA; Li JG; Grabbe C; Shapiro M; Pouton CW; Coupar IM
Pharmacology; 2010; 85(4):224-33. PubMed ID: 20299822
[TBL] [Abstract][Full Text] [Related]
2. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
[TBL] [Abstract][Full Text] [Related]
3. Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).
Brattelid T; Kvingedal AM; Krobert KA; Andressen KW; Bach T; Hystad ME; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):616-28. PubMed ID: 15118808
[TBL] [Abstract][Full Text] [Related]
4. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.
Candura SM; Messori E; Franceschetti GP; D'Agostino G; Vicini D; Tagliani M; Tonini M
Br J Pharmacol; 1996 Aug; 118(8):1965-70. PubMed ID: 8864530
[TBL] [Abstract][Full Text] [Related]
5. Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants.
Krobert KA; Brattelid T; Levy FO; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):473-9. PubMed ID: 16012870
[TBL] [Abstract][Full Text] [Related]
6. Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain.
Dumuis A; Sebben M; Monferini E; Nicola M; Turconi M; Ladinsky H; Bockaert J
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):245-51. PubMed ID: 1650917
[TBL] [Abstract][Full Text] [Related]
7. Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat.
Armstrong SR; McCullough JL; Beattie DT
J Pharmacol Toxicol Methods; 2006; 53(3):198-205. PubMed ID: 16168678
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285.
Dumuis A; Gozlan H; Sebben M; Ansanay H; Rizzi CA; Turconi M; Monferini E; Giraldo E; Schiantarelli P; Ladinsky H
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):264-9. PubMed ID: 1320204
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
Blondel O; Gastineau M; Dahmoune Y; Langlois M; Fischmeister R
J Neurochem; 1998 Jun; 70(6):2252-61. PubMed ID: 9603189
[TBL] [Abstract][Full Text] [Related]
10. Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding.
Schiavi GB; Brunet S; Rizzi CA; Ladinsky H
Neuropharmacology; 1994; 33(3-4):543-9. PubMed ID: 7984293
[TBL] [Abstract][Full Text] [Related]
11. A 5-HT4-like receptor in human right atrium.
Kaumann AJ; Sanders L; Brown AM; Murray KJ; Brown MJ
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):150-9. PubMed ID: 1658664
[TBL] [Abstract][Full Text] [Related]
12. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
[TBL] [Abstract][Full Text] [Related]
13. Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium.
Blondel O; Vandecasteele G; Gastineau M; Leclerc S; Dahmoune Y; Langlois M; Fischmeister R
FEBS Lett; 1997 Aug; 412(3):465-74. PubMed ID: 9276448
[TBL] [Abstract][Full Text] [Related]
14. Serotonin 4 receptor (5-HT4R) internalization is isoform-specific: effects of 5-HT and RS67333 on isoforms A and B.
Mnie-Filali O; Amraei MG; Benmbarek S; Archer-Lahlou E; Peñas-Cazorla R; Vilaró MT; Boye SM; Piñeyro G
Cell Signal; 2010 Mar; 22(3):501-9. PubMed ID: 19922792
[TBL] [Abstract][Full Text] [Related]
15. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
[TBL] [Abstract][Full Text] [Related]
17. In-vivo rat striatal 5-HT4 receptor occupancy using non-radiolabelled SB207145.
Nirogi R; Kandikere V; Bhyrapuneni G; Saralaya R; Ajjala DR; Aleti RR; Rasheed MA
J Pharm Pharmacol; 2013 May; 65(5):704-12. PubMed ID: 23600388
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies.
Ray AM; Kelsell RE; Houp JA; Kelly FM; Medhurst AD; Cox HM; Calver AR
Eur J Pharmacol; 2009 Feb; 604(1-3):1-11. PubMed ID: 19100256
[TBL] [Abstract][Full Text] [Related]
19. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
